NCT03192267 Early Rheumatoid Arthritis Lung Disease Study
| NCT ID | NCT03192267 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Nebraska |
| Condition | Rheumatoid Arthritis |
| Study Type | OBSERVATIONAL |
| Enrollment | 125 participants |
| Start Date | 2017-03-31 |
| Primary Completion | 2029-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 125 participants in total. It began in 2017-03-31 with a primary completion date of 2029-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Extra-articular (outside of joints) disease occurs in approximately 50% of rheumatoid arthritis (RA) patients, with the lung being a common site of involvement. The goals of this study are to investigate and characterize lung disease and its prevalence in early RA participants. This will be done through pulmonary function and high resolution chest computed tomography (CT), questionnaires, and serum studies. Another goal is to find novel biomarkers, such anti-malondialdehyde-acetaldehyde (MAA) antibodies, as predictors of lung disease in RA participants.
Eligibility Criteria
Inclusion Criteria: * 19-90 years of age * Able to give informed consent * Diagnosis of RA by a Rheumatologist using 2010 American College of Rheumatology (ACR) criteria within the past 2 years Exclusion Criteria: * Inflammatory arthritis that does not meet 2010 American College of Rheumatology (ACR) criteria for rheumatoid arthritis (RA) * Pregnant
Contact & Investigator
Tina D Mahajan, MD
STUDY CHAIR
University of Nebraska
Frequently Asked Questions
Who can join the NCT03192267 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, up to 90 Years, studying Rheumatoid Arthritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03192267 currently recruiting?
Yes, NCT03192267 is actively recruiting participants. Contact the research team at aischreiner@unmc.edu for enrollment information.
Where is the NCT03192267 trial being conducted?
This trial is being conducted at Omaha, United States.
Who is sponsoring the NCT03192267 clinical trial?
NCT03192267 is sponsored by University of Nebraska. The principal investigator is Tina D Mahajan, MD at University of Nebraska. The trial plans to enroll 125 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.